Cargando…

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors

Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to treat patients. Its diverse TCR clonality, superior tumor-homing ability, and low off-target toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuhang, Sun, Jingwei, Chen, Kun, Ma, Peiwen, Lei, Qi, Xing, Shujun, Cao, Zhongzheng, Sun, Shujun, Yu, Zicheng, Liu, Yarong, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194199/ https://www.ncbi.nlm.nih.gov/pubmed/34112147 http://dx.doi.org/10.1186/s12916-021-02006-4

Ejemplares similares

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

The state of the art of bispecific antibodies for treating human malignancies
por: Wang, Shuhang, et al.
Publicado: (2021)

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
por: Wang, Shuhang, et al.
Publicado: (2022)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022)

Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy
por: Wang, Shuhang, et al.
Publicado: (2021)

Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
por: Li, Biaoru
Publicado: (2022)

Solid Tumor-Targeted Infiltrating Cytotoxic T Lymphocytes Retained by a Superantigen Fusion Protein
por: Sun, Jialin, et al.
Publicado: (2011)

Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma
por: Shi, Lijun, et al.
Publicado: (2017)

Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors
por: Bronger, Holger, et al.
Publicado: (2019)

Tumor-infiltrating CD45RO(+) Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
por: Hu, Guoming, et al.
Publicado: (2017)

Prognostic role of tumor-infiltrating CD57-positive lymphocytes in solid tumors: a meta-analysis
por: Hu, Guoming, et al.
Publicado: (2017)

Tumor infiltrating lymphocytes and radiological picture of the tumor
por: Frankowska, Karolina, et al.
Publicado: (2023)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
por: Bellone, Matteo, et al.
Publicado: (2013)

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
por: Knochelmann, Hannah M, et al.
Publicado: (2021)

Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme
por: Feng, Lin, et al.
Publicado: (2017)

Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer
por: Liao, Rong, et al.
Publicado: (2021)

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
por: Liu, Dong, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer
por: He, Mengdi, et al.
Publicado: (2021)

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
por: Yue, Qi, et al.
Publicado: (2013)

Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities
por: Kovacsovics-Bankowski, Magdalena, et al.
Publicado: (2014)

Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers
por: Tas, Liselotte, et al.
Publicado: (2023)

Single-Cell Profiling of the Immune Atlas of Tumor-Infiltrating Lymphocytes in Endometrial Carcinoma
por: Jiang, Fang, et al.
Publicado: (2022)

The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer
por: Sun, Ying, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases
por: Jakubowska, Katarzyna, et al.
Publicado: (2019)

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
por: Xu, Fei-Fei, et al.
Publicado: (2021)

Relevance of tumor-infiltrating lymphocytes in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2015)

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
por: Milne, Katy, et al.
Publicado: (2012)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
por: Hall, MacLean, et al.
Publicado: (2016)

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
por: Cohen, Ivan J, et al.
Publicado: (2017)

Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer
por: Li, Xinyue, et al.
Publicado: (2022)

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis
por: Zheng, Xiao, et al.
Publicado: (2017)

Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma
por: Lin, Zhi-qiang, et al.
Publicado: (2022)

Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
por: Zhang, Chaoting, et al.
Publicado: (2022)

Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
por: Jung, In Kook, et al.
Publicado: (2014)

Identification of Prognostic Biomarkers for Multiple Solid Tumors Using a Human Villi Development Model
por: Zhang, Botao, et al.
Publicado: (2020)

Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections
por: Du, Min, et al.
Publicado: (2022)

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
por: Kverneland, Anders Handrup, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2c4pin24rcholf937b18qlltkj